PKCδ thus appears to be an additional molecular target in CTCL for the induction of apoptosis, which may further suggest its therapeutic targeting by PEP005 or by other related strategies. The gene discussed is PRKCD; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.